A Nomogram to Predict Disease-Free Survival Following Neoadjuvant Chemotherapy for Triple Negative Breast Cancer

BACKGROUND: Neoadjuvant chemotherapy (NACT) is considered a standard treatment strategy for locally advanced triple negative breast cancer (TNBC). TNBC patients who achieve a pathologic complete response (pCR) are predicted to have a better prognosis while unfavorable chemo-sensitivity is still asso...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Meizhen, Liang, Chenlu, Zhang, Fanrong, Zhu, Liang, Chen, Daobao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8566908/
https://www.ncbi.nlm.nih.gov/pubmed/34745934
http://dx.doi.org/10.3389/fonc.2021.690336

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8566908/
https://www.ncbi.nlm.nih.gov/pubmed/34745934
http://dx.doi.org/10.3389/fonc.2021.690336

Ejemplares similares